STOCK TITAN

CorVel Q2 FY2027 diluted EPS rises 24% to $0.67

Quarterly gross profit and diluted earnings per share each increased 24% year over year, and CorVel reported no borrowings at quarter-end.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

CorVel Corporation (CRVL) reported second-quarter fiscal 2027 revenue of $267.129 million, up 11% from the September 2025 quarter, and diluted earnings per share of $0.67, up 24% from $0.54. Gross profit was $72.299 million, up 24%, with a 27% gross margin. For the six months ended September 30, 2026, revenue was $527.054 million, compared with $474.354 million, and diluted earnings per share was $1.31, compared with $1.06.

CorVel ended the quarter with $269.988 million in cash and cash equivalents and no borrowings, and repurchased $18.1 million of common stock during the quarter. The company cited customer wins and deeper client relationships in its workers' compensation and liability businesses. Other updates included AI integration in claims workflows, an additional Top 10 national health plan implementation at CERIS, and a partnership providing access to the Blue Cross Blue Shield market.

3 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 0 points

How the balance works

Positive

  • Moderate pointQuarterly revenue rose 11% to $267 million in fiscal 2027's second quarter.
  • Moderate pointQuarterly gross profit rose 24% to $72.3 million in fiscal 2027's second quarter.
  • Moderate pointQuarterly diluted EPS rose 24% to $0.67 in fiscal 2027's second quarter.

Negative

  • None.
Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Quarterly revenue $267.129 million Quarter ended September 30, 2026; up 11% from the September 2025 quarter
Quarterly gross profit $72.299 million Quarter ended September 30, 2026; up 24% from the September 2025 quarter
Quarterly diluted earnings per share $0.67 per share Quarter ended September 30, 2026; up 24% from the September 2025 quarter
Six-month revenue $527.054 million Six months ended September 30, 2026; compared with $474.354 million in the prior-year period
Six-month diluted earnings per share $1.31 per share Six months ended September 30, 2026; compared with $1.06 in the prior-year period
Cash and cash equivalents $269.988 million September 30, 2026
Common stock repurchased $18.1 million During the quarter ended September 30, 2026
gross margin financial
"at 27% gross margin"
Gross margin is the difference between how much money a company makes from selling its products and how much it costs to produce them, expressed as a percentage of sales. It shows how efficiently a company is turning sales into profit before other expenses like marketing or salaries. Higher gross margin means the company keeps more money from each sale, which is a good sign of financial health.
diluted earnings per share financial
"Second Quarter Fiscal Year 2027 Highlights"
Diluted earnings per share is a measure of a company's profit allocated to each share of stock, taking into account all possible shares that could be created through stock options, convertible bonds, or other securities. It shows the lowest possible earnings per share if all these potential shares were issued, helping investors understand the worst-case scenario for their ownership. This figure matters because it provides a more conservative view of a company's profitability per share.
out-of-network medical repricing medical
"approach to out-of-network medical repricing"
prepayment services medical
"CERIS' prepayment services"
Quarterly revenue $267.129 million up 11% year over year
Quarterly gross profit $72.299 million up 24% year over year
Quarterly diluted earnings per share $0.67 per share up 24% year over year
Six-month revenue $527.054 million up from $474.354 million in the prior-year period
Six-month diluted earnings per share $1.31 per share up from $1.06 per share in the prior-year period

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What revenue and diluted EPS did CRVL report for the quarter ended September 30, 2026?

CorVel reported $267.129 million in revenue and $0.67 diluted EPS for the quarter ended September 30, 2026. Revenue was up 11% and diluted EPS was up 24% compared with the September 2025 quarter.

What were CRVL's revenue and diluted EPS for the six months ended September 30, 2026?

CorVel reported $527.054 million in revenue and $1.31 diluted EPS for the six months ended September 30, 2026. The comparable prior-year figures were $474.354 million in revenue and $1.06 diluted EPS.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false0000874866CORVEL CORPORATION00008748662026-11-032026-11-03

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 03, 2026

 

 

CORVEL CORPORATION

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

000-19291

33-0282651

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

5128 Apache Plume Road

Suite 400

 

Fort Worth, Texas

 

76109

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (817) 390-1416

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, Par Value $0.0001 Per Share

 

CRVL

 

Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 


Item 2.02 Results of Operations and Financial Condition.

 

On November 3, 2026, CorVel Corporation (the "Company") issued a press release announcing its financial results for the three and six months ended September 30, 2026. A copy of the press release is furnished herewith as Exhibit 99.1.

 

The information contained in this Item 2.02 and in the exhibit attached to this report as Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, or incorporated by reference in any filing of the Company under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

Exhibit

Number

Description

 99.1

Press Release, dated November 3, 2026, announcing CorVel Corporation’s financial results for the three and six months ended September 30, 2026 (furnished herewith but not filed pursuant to Item 2.02).

 104

Cover Page Interactive Data file (embedded within the Inline XBRL document).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

CORVEL CORPORATION,
a Delaware corporation
(Registrant)

 

 

 

 

Date:

November 3, 2026

By:

/s/ Brian S. Nichols

 

 

 

Brian S. Nichols
Chief Financial Officer

 


 

Exhibit 99.1

 

Date: November 3, 2026

 

CorVel Corporation

 

 

5128 Apache Plume Road

 

 

Suite 400

 

 

Fort Worth, TX 76109

 

 

 

FOR IMMEDIATE RELEASE

 

Contact: Melissa Storan

 

 

Phone: 949-851-1473

 

 

www.corvel.com

 

CorVel Announces Revenues and Earnings

FORT WORTH, Texas, November 3, 2026 — CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter ended September 30, 2026. Revenues for the quarter were $267 million, an increase from $240 million in the September quarter of 2025. Earnings per share for the quarter were $0.67, compared to $0.54 in the same quarter of the prior year. Revenues for the six months ended September 30, 2026 were $527 million, an increase from $474 million for the six months ended September 30, 2025. Earnings per share for the six months ended September 30, 2026 were $1.31, compared to $1.06 during the six months ended September 30, 2025.

 

Second Quarter Fiscal Year 2027 Highlights

 

•
Revenue increased 11% to $267 million, compared to second quarter of fiscal year 2026.
•
Gross profit increased 24% to $72.3 million, at 27% gross margin, compared to second quarter of fiscal year 2026 gross profit of $58.2 million.
•
Diluted earnings per share increased 24% to $0.67, compared to second quarter of fiscal year 2026 diluted earnings per share of $0.54.
•
The Company exited the quarter with $270 million of cash, cash equivalents, and no borrowings.
•
The Company repurchased $18.1 million of common stock during the quarter.

CorVel generated strong momentum in its workers' compensation and liability businesses through new customer wins and deeper relationships with existing clients. As employers and insurers face greater claim complexity, rising medical costs, and increasing administrative demands, the Company's integrated claims management and managed care model brings together clinical expertise, technology, and cost containment solutions to improve patient outcomes and manage total claim costs.

 

Technology innovation remains central to CorVel's efforts to modernize claims administration and increase operational capacity. The integration of artificial intelligence into core claims workflows is reducing manual processes and providing adjusters with more timely, actionable information. Recent developments within CareMC and MyCare, a digital self-service portal, are improving communication and access to claim information. Within Network Solutions, the introduction of Marketwise RepricingTM provides a more sophisticated approach to out-of-network medical repricing, while investments in pharmacy benefits management strengthen pricing, network access, and clinical oversight.

 

CERIS gained further traction among the nation's largest healthcare payers with the implementation of an additional Top 10 national health plan and a strategic partnership providing access to the Blue Cross Blue Shield market. Product development efforts include new Hospital Bill Audit and Professional Claims solutions, extending the scope of CERIS' prepayment services to address complex reimbursement challenges. Together, these initiatives position CERIS to deepen customer relationships, reach new markets, and deliver greater value to health plans seeking improved payment accuracy and control over healthcare expenditures.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

 

All statements included in this press release, other than statements or characterizations of historical fact, are forward-looking statements. These forward-looking statements are based on the Company’s current expectations, estimates and projections about the Company, management’s beliefs, and certain assumptions made by the

 


 

Company, and events beyond the Company’s control, all of which are subject to change. Such forward-looking statements include, but are not limited to, improved payment accuracy and reducing costs, improving program performance and achieving better outcomes with operational expertise combined with advanced technology. These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause the Company’s actual results to differ materially and adversely from those expressed in any forward-looking statement. The risks and uncertainties referred to above include but are not limited to factors described in this press release and the Company’s filings with the Securities and Exchange Commission, including but not limited to “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended March 31, 2026, and the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026. The forward-looking statements in this press release speak only as of the date they are made. The Company undertakes no obligation to revise or update publicly any forward-looking statement for any reason.

 

 

 

 

 

 


 

CorVel Corporation

Quarterly Results – Income Statement

Quarters and Six Months Ended September 30, 2026 (unaudited) and September 30, 2025 (unaudited)

 

Quarter Ended

 

September 30, 2026

 

 

September 30, 2025

 

Revenues

 

$

267,129,000

 

 

$

239,643,000

 

Cost of revenues

 

 

194,830,000

 

 

 

181,466,000

 

Gross profit

 

 

72,299,000

 

 

 

58,177,000

 

General and administrative

 

 

26,454,000

 

 

 

22,277,000

 

Income from operations

 

 

45,845,000

 

 

 

35,900,000

 

Income tax provision

 

 

11,758,000

 

 

 

7,994,000

 

Net income

 

$

34,087,000

 

 

$

27,906,000

 

Earnings Per Share:

 

 

 

 

 

 

Basic

 

$

0.67

 

 

$

0.54

 

Diluted

 

$

0.67

 

 

$

0.54

 

Weighted Shares

 

 

 

 

 

 

Basic

 

 

50,545,000

 

 

 

51,314,000

 

Diluted

 

 

50,690,000

 

 

 

51,723,000

 

 

Six Months Ended

 

September 30, 2026

 

 

September 30, 2025

 

Revenues

 

$

527,054,000

 

 

$

474,354,000

 

Cost of revenues

 

 

386,961,000

 

 

 

359,552,000

 

Gross profit

 

 

140,093,000

 

 

 

114,802,000

 

General and administrative

 

 

50,907,000

 

 

 

43,619,000

 

Income from operations

 

 

89,186,000

 

 

 

71,183,000

 

Income tax provision

 

 

22,874,000

 

 

 

16,042,000

 

Net income

 

$

66,312,000

 

 

$

55,141,000

 

Earnings Per Share:

 

 

 

 

 

 

Basic

 

$

1.31

 

 

$

1.07

 

Diluted

 

$

1.31

 

 

$

1.06

 

Weighted Shares

 

 

 

 

 

 

Basic

 

 

50,675,000

 

 

 

51,333,000

 

Diluted

 

 

50,809,000

 

 

 

51,817,000

 

 

 


 

CorVel Corporation

Quarterly Results – Condensed Balance Sheet

September 30, 2026 (unaudited) and March 31, 2026

 

 

 

September 30, 2026

 

 

March 31, 2026

 

Cash

 

$

269,988,000

 

 

$

233,072,000

 

Customer deposits

 

 

130,464,000

 

 

 

115,706,000

 

Accounts receivable, net

 

 

108,396,000

 

 

 

101,313,000

 

Prepaid taxes and expenses

 

 

11,860,000

 

 

 

12,206,000

 

Property, net

 

 

124,418,000

 

 

 

117,906,000

 

Goodwill and other assets

 

 

42,779,000

 

 

 

41,619,000

 

Right-of-use asset, net

 

 

25,692,000

 

 

 

21,146,000

 

Total

 

$

713,597,000

 

 

$

642,968,000

 

Accounts and taxes payable

 

$

23,563,000

 

 

$

24,550,000

 

Accrued liabilities

 

 

233,889,000

 

 

 

203,518,000

 

Long-term lease liabilities

 

 

25,643,000

 

 

 

20,687,000

 

Paid-in capital

 

 

279,042,000

 

 

 

268,518,000

 

Treasury stock

 

 

(928,281,000

)

 

 

(887,716,000

)

Retained earnings

 

 

1,079,741,000

 

 

 

1,013,429,000

 

Total

 

$

713,597,000

 

 

$

642,986,000

 

 

 


Filing Exhibits & Attachments

2 documents

Keep reading